Star Combo Pharma Limited

S66

AU0000004798

Other Specialty Retailers

Market Closed - Australian S.E. Other stock markets 08:16:30 2024-06-04 pm EDT			5-day change	1st Jan Change
0.11 ^AUD	-8.33%		-8.33%	-24.14%

Feb. 27	Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
2023	Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2019

February 26, 2020 at 12:18 am EST

Star Combo Pharma Limited announced earnings results for the half year ended December 31, 2019. For the half year, the company announced sales was AUD 21.142 million compared to AUD 5.868 million a year ago. Net loss was AUD 1.232 million compared to AUD 1.327 million a year ago. Basic loss per share was AUD 0.0001 compared to AUD 0.0002 a year ago.

Latest news about Star Combo Pharma Limited

Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 26	CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29	CI
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26	CI
An unknown buyer acquired 49% stake in Austoyou Group Pty Ltd and Koala Mall Pty Ltd from Star Combo Pharma Limited.	23-02-23	CI
Star Combo Pharma Limited Announces Resignation of Ziye Sui as Non- Executive Director	22-08-29	CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-23	CI
Star Combo Pharma Issues Shares to Vietnamese Distributor	22-07-05	MT
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-23	CI
Star Combo Pharma Limited Announces Group Revenue Results for the Second Quarter Ended 31 December 2021	22-01-30	CI
Star Combo Pharma Limited Announces Supplementary Announcement on New Contract	21-11-08	CI
Australian Shares Extend Gains as IT, Financial Counters Offset Losses in Energy	21-11-04	MT
Star Combo Pharma Secures Nearly $4 Million Order for Bulk Capsules	21-11-04	MT
Star Combo Pharma Limited Receives $5.0 Million Order	21-11-03	CI
Star Combo Pharma : Signs Deal for Health Supplement Distribution to Vietnam	21-10-10	MT
Star Combo Signs 12-Month Exclusive Distribution Agreement with Happy Co. Ltd for Widespread Sales and Distribution of its Proprietary Health Supplement Product Line, Costar Across Vietnam	21-10-10	CI
Star Combo Pharma : Secures Approval for New Research and Development Facility	21-09-06	MT
Star Combo Pharma Limited Announces Development Application Approval Receives for R&D Facilities At Smithfield	21-09-05	CI
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2020	21-02-23	CI
Star Combo Pharma : Fiscal Q2 Revenue Up 6%	21-02-01	MT
Star Combo Pharma Limited Continues to Progress its Contract Manufacturing Expansion Strategy	20-11-02	CI
Star Combo Pharma Limited Announces the Expansion of Its Manufacturing Capabilities At Its Wholly-Owned Tga-Licensed Nutraceutical Manufacturing Site	20-08-31	CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-08-25	CI
Star Combo Pharma Limited Completes the Purchase of Land Located At 165 Woodpark Road, Smithfield, New South Wales	20-08-06	CI
Star Combo Pharma Limited Expands Capacity - Milk Powder Blend and Pack Facility	20-08-03	CI
Star Combo Pharma Limited Announces Board Changes	20-05-26	CI

Chart Star Combo Pharma Limited

Duration

Period

More charts

Company Profile

Star Combo Pharma Limited is an Australia-based company that is primarily engaged in the manufacture and distribution of health and natural beauty products. The Company operates through two segments: Star Combo business and Austoyou retail. The Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment is made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers. The Companyâs product categories include Costar, Living Healthy, Amax and J&K. The Company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance. The Companyâs wholly owned subsidiaries include CoStar Pharma Laboratory Pty Ltd and Star Combo Australia Pty Ltd.

Sector

Other Specialty Retailers

Calendar

2024-08-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Health Food Stores

	1st Jan change	Capi.
STAR COMBO PHARMA LIMITED	-24.14%	9.78M
THE BETTER BEING CO.	-.--%	843M
DXN HOLDINGS BHD.	+5.51%	710M
NATURAL GROCERS BY VITAMIN COTTAGE, INC.	+30.38%	475M
ZINZINO AB	+22.65%	238M
MARX BIOTECH CO., LTD.	0.00%	162M
NANJING SINOLIFE UNITED COMPANY LIMITED	+113.04%	59.36M